statistiche ricercatore

Continente	#
NA - Nord America	744
EU - Europa	293
AS - Asia	258
SA - Sud America	86
Continente sconosciuto - Info sul continente non disponibili	62
AF - Africa	17
Totale	1.460

Nazione	#
US - Stati Uniti d'America	721
SG - Singapore	96
IT - Italia	85
BR - Brasile	74
CN - Cina	57
RU - Federazione Russa	53
DE - Germania	52
SE - Svezia	28
VN - Vietnam	26
HK - Hong Kong	23
GB - Regno Unito	21
IN - India	14
FR - Francia	13
BD - Bangladesh	12
FI - Finlandia	10
CA - Canada	8
BE - Belgio	7
PL - Polonia	6
TR - Turchia	6
MX - Messico	5
AR - Argentina	4
CI - Costa d'Avorio	4
CR - Costa Rica	4
EC - Ecuador	4
NL - Olanda	4
UA - Ucraina	4
AL - Albania	3
ID - Indonesia	3
JM - Giamaica	3
JP - Giappone	3
NP - Nepal	3
SC - Seychelles	3
VE - Venezuela	3
EG - Egitto	2
ES - Italia	2
IQ - Iraq	2
KZ - Kazakistan	2
SA - Arabia Saudita	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
AE - Emirati Arabi Uniti	1
BY - Bielorussia	1
CG - Congo	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
GN - Guinea	1
GT - Guatemala	1
HR - Croazia	1
IE - Irlanda	1
IL - Israele	1
IM - Isola di Man	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KR - Corea	1
LT - Lituania	1
LY - Libia	1
MY - Malesia	1
PH - Filippine	1
PK - Pakistan	1
SN - Senegal	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	1.399

Nome	#
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid	219
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate	216
Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity	210
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia	173
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo	170
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels	160
Functional characterization of a C-terminal Nav1.4 mutation found in a patient presenting with myotonia and congenital myasthenia syndrome	137
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels	96
Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability	79
Totale	1.460

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	51	0	0	0	0	2	2	1	4	1	12	10	19
2022/2023	101	10	16	8	5	9	18	2	10	14	2	5	2
2023/2024	44	2	8	5	8	7	10	0	1	1	0	0	2
2024/2025	224	14	1	11	14	22	17	36	40	8	9	19	33
2025/2026	484	63	21	43	66	64	32	31	10	64	32	11	47
2026/2027	94	11	16	21	42	4	0	0	0	0	0	0	0
Totale													1.460